Page last updated: 2024-11-02

pamidronate and Rett Syndrome

pamidronate has been researched along with Rett Syndrome in 2 studies

Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)

Research Excerpts

ExcerptRelevanceReference
"Pamidronate was well tolerated."1.46Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility. ( Bahi-Buisson, N; Brailly-Tabard, S; Célestin, E; Charles, P; Durand, E; Fontaine, I; Lambert, AS; Linglart, A; Miladi, L; Rothenbuhler, A; Trabado, S; Wicart, P, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambert, AS1
Rothenbuhler, A1
Charles, P1
Brailly-Tabard, S1
Trabado, S1
Célestin, E1
Durand, E1
Fontaine, I1
Miladi, L1
Wicart, P1
Bahi-Buisson, N1
Linglart, A1
Lotan, M1
Reves-Siesel, R1
Eliav-Shalev, RS1
Merrick, J1

Other Studies

2 other studies available for pamidronate and Rett Syndrome

ArticleYear
Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Calcium; Child; Creatinine; Dipho

2017
Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:12

    Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infant; Osteoporosis

2013